Modeling osteoporosis to design and optimize pharmacologic therapies comprising multiple drug types
D. J. Jörg, D. H. Fuertinger, A. Cherif, D. A. Bushinsky, A. Mermelstein, J. G. Raimann, P. Kotanko
The paper develops a mathematical model to optimize drug combinations for postmenopausal osteoporosis by simulating synergistic effects of different drug classes.
bioRxiv · Dec 17, 2021 · PreprintPharmacology & Toxicology